Peptide injection sites: where subcutaneous shots go, and how to rotate them

“Where do you inject peptides?” is one of the most-asked practical questions in this whole category, and it has a genuinely simple answer for the technique itself: almost all of the research peptides and GLP-1 medications people discuss are given as subcutaneous injections into the fat layer just under the skin, at a small set of standard body sites that you rotate between. This guide covers those sites, the subcutaneous-versus-intramuscular distinction, why rotation matters, and the sterile-technique basics. One honesty note before anything else: many of the peptides written about online are research-use-only and not approved for human use. What follows is harm-reduction information about injection technique — it is not an endorsement to self-inject unapproved substances, and if you have been prescribed an injectable, your clinician’s instructions override anything here.

Subcutaneous vs intramuscular: nearly always subQ

The first thing to get straight is the layer. A subcutaneous (subQ) injection deposits the solution into the fatty tissue between skin and muscle; an intramuscular (IM) injection goes deeper, into the muscle itself. These are different techniques with different needles, angles and sites, and they are not interchangeable. The overwhelming majority of the peptides and incretin drugs people ask about — semaglutide, tirzepatide and the common research peptides — are formulated and administered subcutaneously. The FDA-approved label for a GLP-1 such as Ozempic (semaglutide) is explicit: it directs the medication to be injected subcutaneously in the abdomen, thigh or upper arm.^[3] If a source is telling you to inject a peptide into muscle, that is a departure from how these agents are normally given and a reason to stop and check with a clinician, not to improvise.

The route also shapes the earlier steps. A subcutaneous peptide is typically a small volume of a reconstituted solution — which is a whole preparation problem of its own, from reconstituting the powder to choosing the right diluent, usually bacteriostatic water. Those upstream decisions determine what is actually in the syringe long before the question of where it goes.

The standard subcutaneous sites

Subcutaneous injections work best where there is a reliable layer of fat you can pinch, away from bones, large blood vessels, nerves and the navel. In practice that means a short list of well-worn sites, which is exactly what diabetes injection-technique guidance has converged on:

• Abdomen — the belly is the classic subcutaneous site, staying roughly a couple of inches (about 5 cm) away from the navel in any direction and avoiding the waistband line. It offers a large, easy-to-pinch area with generally consistent absorption.
• Outer thigh — the front-outer part of the upper thigh, the fleshy area roughly a hand’s width down from the hip and up from the knee.
• Back of the upper arm — the fatty area at the back of the upper arm. It is harder to reach one-handed, so it is often used with help, but it is a recognized subcutaneous site.
• Upper buttock or flank — the upper outer quadrant of the buttock / the love-handle area, another region with dependable subcutaneous fat.

International injection-technique recommendations describe this same family of subcutaneous sites and stress using the full area available at each one rather than a single favored spot.^[1] The mechanics of actually delivering into that layer — pinching, angle, needle length — are a separate topic we cover in how to inject peptides; here the point is simply the map of where.

Rotate your sites — this is the part people skip

Choosing a site is only half the answer. The other half is not using the same spot over and over. Repeated injection into one small area is a well-documented cause of lipohypertrophy — rubbery, thickened lumps of subcutaneous tissue that build up where the skin is punctured again and again. A 2025 systematic meta-analysis of people with insulin-treated diabetes identified failure to rotate sites, along with reusing needles, among the modifiable risk factors most consistently associated with developing lipohypertrophy.^[2] The official injection-technique consensus makes the same point and recommends rotating in a structured way, spacing consecutive injections apart and moving across the whole available area.^[1]

Lipohypertrophy is not only a cosmetic nuisance. Injecting into those altered lumps makes absorption erratic and unpredictable — which for any dose-sensitive agent means you no longer really know how much is getting in. The practical habit is straightforward: move to a different spot each time, keep a rough mental (or written) rotation across and between sites, and never inject into skin that is lumpy, bruised, tender, scarred or inflamed.

Sterile technique basics

The instant a solution goes under the skin, contamination becomes a real risk, so basic aseptic habits are non-negotiable. None of this is exotic; it is the same handful of steps clinical guidance has emphasized for decades:

• Clean hands — wash thoroughly with soap and water (or use a hand sanitizer) before handling anything.
• Swab the skin — wipe the chosen site with an alcohol swab and, importantly, let it dry fully before the needle goes in.
• A new sterile needle every time — reusing needles both dulls them and is itself a documented risk factor for lipohypertrophy and skin problems.^[2] One needle, one injection, then discard.
• Never share needles, syringes or pen devices — this is a bloodborne-infection route.
• Dispose into a sharps container — used needles go straight into an FDA-cleared sharps disposal container, never loose into household trash; the FDA publishes guidance on safe home sharps disposal.^[4]

Storage sits alongside sterility as the other thing that quietly determines whether what you inject is still sound — reconstituted peptides are far less stable than the dry powder, which is why how you store them matters as much as how you handle the needle.

The honest bottom line

The technique question has a clean answer: peptides in this category are almost always given subcutaneously, into the abdomen (clear of the navel), the outer thigh, the back of the upper arm, or the upper buttock/flank — rotating sites every time to avoid lipohypertrophy, with clean hands, a dried alcohol swab, a fresh needle and a sharps container. But knowing where the needle goes does not resolve the harder questions that sit upstream: whether a given peptide is legal to obtain, whether the vial actually contains what its label claims, and whether you should be injecting it at all. Most research peptides are not approved for human use, and the gray-market supply is repeatedly found to be mislabeled or impure — which is why the sourcing question, covered in where to get peptides safely, is the one that really matters. Treat everything here as harm-reduction information about technique, not a green light to self-inject unapproved substances. If you have a prescribed injectable, follow your clinician’s instructions — they, not an article, are accountable for your dose.